The rise of obesity in Britain could be halted if exercise were built into individual daily routines, according to new …
Genmab and GSK's new biotech drug HuMax has entered phase III trials for use in rheumatoid arthritis, the first of …
First, the good news. So easy to overlook when the headlines are filled with tales of threats to close A&E …
Access licenses MuGard to Rhei Pharmaceuticals Access Pharmaceuticals and Rhei Pharmaceuticals have signed a definitive licensing agreement under which Rhei …
Swiss pharmaceutical company Roche is to invest $390 million (430 million Swiss francs) in three of its European sites to …
Pharmaceutical companies across Europe have been raided by EU investigators who suspect illegal moves to block the launch of cheaper …
A look back at some of the biggest stories to affect the UK pharmaceutical industry in 2007, including a string …
The entry of three generic competitors and the withdrawal of irritable bowel drug Zelnorm wiped billions off Novartis' revenues in …
Pharmaceutical marketing and the NHS drugs bill are once again in the spotlight with MPs criticising the industry's influence and …
US market research company Manhattan Research has launched a new European service to examine trends in physician's use of technology …
European regulators have approved GlaxoSmithKline's new once-daily corticosteroid nasal spray for allergic rhinitis. Avamys was granted a licence to treat …
AstraZeneca's Crestor will go head-to-head with Pfizer's mega-brand Lipitor in a global trial assessing the two statins in cardiovascular disease. …
Pfizer will partner with German biopharmaceutical company Scil Technology to develop and commercialise a new early-stage biotech treatment for cartilage …
Stakeholders have voiced fresh fears pharma is moving towards advertising prescription medicines to consumers after the European Commission continued in …
The spectacular growth which has made Genentech the world's biggest biotech company is set to slow in 2008, as its …
Patients risk safety by taking biotech medicines that are similar but not the same as the branded drug, MPs have …
Latest results for the mandatory ABPI medical representative exam showed a 75% pass rate, but the numbers sitting the test …
Richard Branson’s Virgin group has launched a new business offshoot which will compete to offer GP services around England.Virgin is …
Cancer Research UK is investing ten million pounds in drug discovery projects at four UK universities. Project leaders at Imperial …
European and Canadian regulators have forged a transatlantic agreement to exchange confidential information about the authorisation and safety of medicines. …